US Stock MarketDetailed Quotes

AXGT Axovant Gene Therapies

Watchlist
  • 0.000
  • 0.0000.00%
Close May 31 09:30 ET
0Market Cap0.00P/E (TTM)

Axovant Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2020
(FY)Mar 31, 2020
(Q4)Mar 31, 2020
(Q3)Dec 31, 2019
(Q2)Sep 30, 2019
(Q1)Jun 30, 2019
(FY)Mar 31, 2019
(Q4)Mar 31, 2019
(Q3)Dec 31, 2018
(Q2)Sep 30, 2018
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-64.32%9.83M
-45.54%69.17M
20.64%16.05M
-57.81%13.68M
-63.01%11.88M
-43.96%27.56M
-40.46%127.02M
-44.66%13.31M
-41.46%32.42M
-53.22%32.12M
Selling and administrative expenses
-28.26%4.64M
-44.10%22.06M
-16.63%5.13M
-50.53%5.41M
-52.45%5.05M
-44.97%6.47M
-45.11%39.47M
174.38%6.16M
-39.37%10.93M
-64.73%10.62M
-General and administrative expense
-28.26%4.64M
-44.10%22.06M
-16.63%5.13M
-50.53%5.41M
-52.45%5.05M
-44.97%6.47M
-45.11%39.47M
174.38%6.16M
-39.37%10.93M
-64.73%10.62M
Research and development costs
-75.37%5.19M
-46.19%47.11M
52.75%10.92M
-61.52%8.27M
-68.22%6.83M
-43.64%21.09M
-38.09%87.55M
-67.20%7.15M
-42.48%21.48M
-44.23%21.5M
Operating profit
64.32%-9.83M
45.54%-69.17M
-20.64%-16.05M
57.81%-13.68M
63.01%-11.88M
43.96%-27.56M
40.46%-127.02M
44.66%-13.31M
41.46%-32.42M
53.22%-32.12M
Net non-operating interest income expense
48.91%-796K
41.87%-4.38M
74.45%-440K
44.07%-1.07M
32.04%-1.31M
20.91%-1.56M
0.20%-7.53M
6.57%-1.72M
2.26%-1.91M
-2.88%-1.93M
Non-operating interest expense
-48.91%796K
-41.87%4.38M
-74.45%440K
-44.07%1.07M
-32.04%1.31M
-20.91%1.56M
-0.20%7.53M
-6.57%1.72M
-2.26%1.91M
2.88%1.93M
Other net income (expense)
88.33%2.07M
-75.82%1.36M
-97.84%127K
789.74%694K
-277.78%-560K
264.22%1.1M
2,561.61%5.62M
1,001.12%5.89M
114.18%78K
340.46%315K
Other non- operating income (expenses)
88.33%2.07M
-75.82%1.36M
-97.84%127K
789.74%694K
-277.78%-560K
264.22%1.1M
2,561.61%5.62M
1,001.12%5.89M
114.18%78K
340.46%315K
Income before tax
69.44%-8.56M
44.01%-72.19M
-79.12%-16.37M
58.98%-14.05M
59.23%-13.76M
45.92%-28.02M
41.57%-128.93M
63.96%-9.14M
40.83%-34.24M
52.26%-33.74M
Income tax
-21.05%30K
229.32%438K
409.89%282K
-117.31%-9K
35.11%127K
-51.28%38K
-85.56%133K
-184.38%-91K
116.67%52K
105.91%94K
Net income
69.37%-8.59M
43.73%-72.63M
-84.04%-16.65M
59.07%-14.04M
58.97%-13.88M
45.93%-28.06M
41.75%-129.07M
64.27%-9.05M
40.77%-34.3M
51.02%-33.84M
Net income continuous Operations
69.37%-8.59M
43.73%-72.63M
-84.04%-16.65M
59.07%-14.04M
58.97%-13.88M
45.93%-28.06M
41.75%-129.07M
64.27%-9.05M
40.77%-34.3M
51.02%-33.84M
Minority interest income
Net income attributable to the parent company
69.37%-8.59M
43.73%-72.63M
-84.04%-16.65M
59.07%-14.04M
58.97%-13.88M
45.93%-28.06M
41.75%-129.07M
64.27%-9.05M
40.77%-34.3M
51.02%-33.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.37%-8.59M
43.73%-72.63M
-84.04%-16.65M
59.07%-14.04M
58.97%-13.88M
45.93%-28.06M
41.75%-129.07M
64.27%-9.05M
40.77%-34.3M
51.02%-33.84M
Basic earnings per share
83.74%-0.2
63.47%-2.93
-4.44%-0.47
70.89%-0.62
72.77%-0.61
68.05%-1.23
51.42%-8.02
75.94%-0.45
50.69%-2.13
56.25%-2.24
Diluted earnings per share
83.74%-0.2
63.47%-2.93
-4.44%-0.47
70.89%-0.62
72.77%-0.61
68.05%-1.23
51.42%-8.02
75.94%-0.45
50.69%-2.13
56.25%-2.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jun 30, 2020(FY)Mar 31, 2020(Q4)Mar 31, 2020(Q3)Dec 31, 2019(Q2)Sep 30, 2019(Q1)Jun 30, 2019(FY)Mar 31, 2019(Q4)Mar 31, 2019(Q3)Dec 31, 2018(Q2)Sep 30, 2018
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -64.32%9.83M-45.54%69.17M20.64%16.05M-57.81%13.68M-63.01%11.88M-43.96%27.56M-40.46%127.02M-44.66%13.31M-41.46%32.42M-53.22%32.12M
Selling and administrative expenses -28.26%4.64M-44.10%22.06M-16.63%5.13M-50.53%5.41M-52.45%5.05M-44.97%6.47M-45.11%39.47M174.38%6.16M-39.37%10.93M-64.73%10.62M
-General and administrative expense -28.26%4.64M-44.10%22.06M-16.63%5.13M-50.53%5.41M-52.45%5.05M-44.97%6.47M-45.11%39.47M174.38%6.16M-39.37%10.93M-64.73%10.62M
Research and development costs -75.37%5.19M-46.19%47.11M52.75%10.92M-61.52%8.27M-68.22%6.83M-43.64%21.09M-38.09%87.55M-67.20%7.15M-42.48%21.48M-44.23%21.5M
Operating profit 64.32%-9.83M45.54%-69.17M-20.64%-16.05M57.81%-13.68M63.01%-11.88M43.96%-27.56M40.46%-127.02M44.66%-13.31M41.46%-32.42M53.22%-32.12M
Net non-operating interest income expense 48.91%-796K41.87%-4.38M74.45%-440K44.07%-1.07M32.04%-1.31M20.91%-1.56M0.20%-7.53M6.57%-1.72M2.26%-1.91M-2.88%-1.93M
Non-operating interest expense -48.91%796K-41.87%4.38M-74.45%440K-44.07%1.07M-32.04%1.31M-20.91%1.56M-0.20%7.53M-6.57%1.72M-2.26%1.91M2.88%1.93M
Other net income (expense) 88.33%2.07M-75.82%1.36M-97.84%127K789.74%694K-277.78%-560K264.22%1.1M2,561.61%5.62M1,001.12%5.89M114.18%78K340.46%315K
Other non- operating income (expenses) 88.33%2.07M-75.82%1.36M-97.84%127K789.74%694K-277.78%-560K264.22%1.1M2,561.61%5.62M1,001.12%5.89M114.18%78K340.46%315K
Income before tax 69.44%-8.56M44.01%-72.19M-79.12%-16.37M58.98%-14.05M59.23%-13.76M45.92%-28.02M41.57%-128.93M63.96%-9.14M40.83%-34.24M52.26%-33.74M
Income tax -21.05%30K229.32%438K409.89%282K-117.31%-9K35.11%127K-51.28%38K-85.56%133K-184.38%-91K116.67%52K105.91%94K
Net income 69.37%-8.59M43.73%-72.63M-84.04%-16.65M59.07%-14.04M58.97%-13.88M45.93%-28.06M41.75%-129.07M64.27%-9.05M40.77%-34.3M51.02%-33.84M
Net income continuous Operations 69.37%-8.59M43.73%-72.63M-84.04%-16.65M59.07%-14.04M58.97%-13.88M45.93%-28.06M41.75%-129.07M64.27%-9.05M40.77%-34.3M51.02%-33.84M
Minority interest income
Net income attributable to the parent company 69.37%-8.59M43.73%-72.63M-84.04%-16.65M59.07%-14.04M58.97%-13.88M45.93%-28.06M41.75%-129.07M64.27%-9.05M40.77%-34.3M51.02%-33.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.37%-8.59M43.73%-72.63M-84.04%-16.65M59.07%-14.04M58.97%-13.88M45.93%-28.06M41.75%-129.07M64.27%-9.05M40.77%-34.3M51.02%-33.84M
Basic earnings per share 83.74%-0.263.47%-2.93-4.44%-0.4770.89%-0.6272.77%-0.6168.05%-1.2351.42%-8.0275.94%-0.4550.69%-2.1356.25%-2.24
Diluted earnings per share 83.74%-0.263.47%-2.93-4.44%-0.4770.89%-0.6272.77%-0.6168.05%-1.2351.42%-8.0275.94%-0.4550.69%-2.1356.25%-2.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg